Phosphatidylserine
Cognitive · Membrane phospholipid
Tier B+
Bottom line
Read Off Label grades Phosphatidylserine as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.
Originally from bovine brain (prion concerns retired that source); current products from soy or sunflower lecithin.
Studied, labeled, or reported-use context: 100-300 mg/day PO — OTC; not individualized guidance.
What the evidence says
Originally from bovine brain (prion concerns retired that source); current products from soy or sunflower lecithin. Starks 2008 showed reduced cortisol response to physical stress. Small studies report outcomes in age-related cognitive complaints; evidence is rated Moderate in this entry. Two 2026 randomized trials, reviewed 2026-08-29. The more interesting one is **vascular, not cognitive**: a double-blind placebo-controlled trial in adults with type 2 diabetes (900 mg/day for 4 weeks, delivering ~280 mg/day PS) improved leg blood flow response to an oral glucose load and reduced load-dependent aortic pulse wave velocity, alongside mechanistic work showing PS binds and inhibits ADAM17 — the enzyme that sheds endothelial insulin receptors. That is a genuinely new mechanism and indication for a supplement sold almost entirely on cognition, though it is one trial in a disease population and says nothing about healthy adults. The second, in 97 professional footballers (randomized, triple-masked, 14 days), found effects on Stroop and visual reaction time, perceived mental fatigue and 30 m sprint — but **PS was given combined with 1,500 mg taurine and 200 mg caffeine**, and while the design includes a taurine+caffeine-only arm to isolate PS, caffeine alone plausibly accounts for much of a reaction-time effect. Neither moves this row's rating; the vascular finding is the one worth watching.
Mechanism
Major acidic phospholipid in neuronal membranes; supports membrane fluidity, receptor density, neurotransmitter release; blunts cortisol response to stress
Studied, labeled, or reported dose & route
100-300 mg/day PO
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
- PubMed · PMID 25933483
- PubMed · PMID 18662395
- pmc.ncbi.nlm.nih.gov
- DOI · 10.1152/japplphysiol.00281.2026
- DOI · 10.3390/nu18162588
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Phosphatidylserine's effects?
- Read Off Label rates the evidence for Phosphatidylserine as Moderate and the benefit magnitude as med, producing an overall grade of B+ (7.1/10). Originally from bovine brain (prion concerns retired that source); current products from soy or sunflower lecithin.
- What safety findings are reported for Phosphatidylserine?
- Phosphatidylserine has a low risk profile in the database. Low (GI upset) Legal status: OTC.
- What doses or routes are reported for Phosphatidylserine?
- 100-300 mg/day PO This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Phosphatidylserine work?
- Major acidic phospholipid in neuronal membranes; supports membrane fluidity, receptor density, neurotransmitter release; blunts cortisol response to stress
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.